SPINK1 and neoplasm: The data from the GO and KEGG analyses inspired the realization that SPINK1 has been engaged in immune response-associated biological processes and signaling pathways in the development of HCC and that it might be a suitable biomarker for the prediction of a “hot” tumor immune microenvironment (TIME) and the response to ICB therapy for HCC.